Immunology Faculty

Program in Immunology

Program Faculty

Associate Member, Clinical Research Division
Gerdin Family Endowed Chair for Leukemia Research, Fred Hutchinson Cancer Research Center
Program Director, Transplantation Pediatric Leukemia , Clinical Research Division
Director, Cellular Therapy and Transplantation for Pediatric Leukemia, Clinical Research Division
Associate Professor, Pediatrics, University of Washington School of Medicine
Laboratory studies are focused on preventing graft-versus-host-disease for children undergoing allogeneic stem cell transplants, the discovery of leukemia associated minor histocompatibility antigens and the development of adoptive T cell immunotherapy.
Phone: (206) 667-6572
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Assistant Professor, Department of Medicine, Division of Medical Oncology, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Research is centered on 1) understanding the factors associated with successful adoptive transfer of immune T cells and improving the outcomes of both native and gene-modified T cells targeting viral and tumor antigens, 2) developing methods that improve the survival, proliferation and anti-tumor activity of infused T-cell products so as to better eliminate tumor targets and 3) clinical strategies to modulate the host immune environment as a means to optimally activate T cells in humans.
Phone: (206) 667-4369
Fax: (206) 667-7983
Assistant Member, Program in Immunology, Clinical Research Division
Understanding the mechanisms underlying endogenous (natural) thymic regeneration so that new therapies might be developed to enhance T-cell immunity, as needed.
Phone: (206) 667-3204
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine
Clinical focus is diagnosis and management of benign and malignant hematologic disorders as well as solid tumors. Research includes developing immune-based approaches to prevent and treat relapse of myeloid cancers, including after allogeneic HSCT.
Phone: (206) 667-4082
Fax: (206) 667-2917
Member & Head, Program in Immunology, Clinical Research Division
Professor of Medicine & Immunotherapy, University of Washington
Basic immunology and cancer immunobiology, and on the development and assessment of adoptive therapies with antigen-specific T cells targeting human malignancies and chronic infections.
Phone: (206) 667-7791
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Studies the cellular and molecular dynamics that underlie metastasis, i.e. the spread of cancer cells from a primary tumor to distant organs. The main focus of his lab is the tumor-immune cell interactions that variably promote or defend against metastasis, particularly in lung cancers.
Phone: (206) 667-3619
Fax: (206) 667-2917
Assistant Member, Clinical Research Division
Tumor infiltrating lymphocyte therapy for melanoma, bladder and head and neck cancers
Phone: (206) 606-2274
Fax: (206) 606-6681
Member, Program in Immunology, Clinical Research Division
Scientific Director, Immunopathology Lab, Clinical Research Division
Mechanisms of tumor-induced immune tolerance by which tumors can escape anti-tumor immune responses, including natural and therapy-induced responses
Phone: (206) 667-6648
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Assistant Professor, Division of Oncology, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Develops new ways to enhance the immune response against sarcomas.
Phone: (206) 667-6629
Fax: (206) 667-7983
Member, Clinical Research Division, Program in Immunology, Program in Immunology
Professor, School of Medicine, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Studies focus on 1) understanding the roles of distinct T cell subsets in protective immunity to pathogens and tumors and on 2) the development and clinical application of adoptive T cell therapies for viral diseases and cancers, using unmodified and genetically modified antigen-specific T cells.
Phone: (206) 667-7791
Fax: (206) 667-7983
Assistant Member, Program in Immunology, Clinical Research Division
Studies the very first steps that lead to a productive immune response. These involve circulating “innate” immune cells that initially recognize problems, such as cells infected by a virus or transformed by malignant changes.
Phone: (206) 667-7753
Fax: (206) 667-7983
Associate Member, Program in Immunology, Clinical Research Division
Associate Professor, Department of Medicine, Division of Oncology, University of Washington School of Medicine
Adjunct Assistant Professor, Department of Bioengineering, University of Washington
Next-generation immunomodulatory synthetic materials, we are developing new approaches to therapeutically boost the body's natural ability to fight cancer
Phone: (206) 667-6677
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Adoptive T cell therapy for hematologic malignancies and in investigating the immunologic perturbations in hematopoietic stem cell transplantation
Phone: (206) 667-7073
Fax: (206) 667-7983
Member, Program in Immunology, Clinical Research Division
Professor of Medicine, Department of Medicine, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Program Head, Global Oncology, Global Oncology
Clinical focus is treating patients with blood cancers such as leukemia, lymphoma, and multiple myeloma. Research is focused on cancer immunology, specifically the mechanisms and molecules that mediate graft-versus-host disease and graft-versus tumor.
Phone: (206) 667-6441
Fax: (206) 667-7983